# 10 - 31.5 Autism Spectrum Disorder

# 31.5 Autism Spectrum Disorder

timed speech treatment for preschool children who stutter. Int J Speech Lang Pathol. 2011;13:500–509.
Verhoeven L, van Balkom H, eds. Classification of Developmental Language Disorders. Theoretical Issues and Clinical
Implications. Mahwah, NJ: Erlbaum; 2004.
Wake M, Levickis P, Tobin S, Zens N, Law J, Gold L, Ukoumunne OC, Goldfield S, Le Ha ND, Skeat J, Reilly S. Improving
outcomes of preschool language delay in the community: Protocol for the Language for Learning randomized controlled
trial. BMC Pediatrics. 2012;12:96–107.
Wake M, Tobin S, Girolametto L, Ukomunne OC, Gold L, Levickis P, Sheehan J, Goldfeld S, Reilly S. Outcomes of
population based language promotion for slow to talk toddlers at ages 2 and 3 years: Let’s Learn Language cluster
randomised clinical trial. BMJ. 2011;343–355.
Yaruss JS, Coleman Ce, Quesal RW. Stuttering in school-age children: A comprehensive approach to treatment. Lang
Speech Hear Serv Sch. 2012;43:536–548.
 31.5 Autism Spectrum Disorder
Autism spectrum disorder, previously known as the pervasive developmental disorders,
is a phenotypically heterogeneous group of neurodevelopmental syndromes, with
polygenic heritability, characterized by a wide range of impairments in social
communication and restricted and repetitive behaviors. Prior to the development of the
Fifth Edition of the American Psychiatric Association’s Diagnostic and Statistical Manual of
Mental Disorders (DSM-5), autism spectrum disorder was conceptualized as five discrete
disorders, including: autistic disorder, Asperger’s disorder, childhood disintegrative disorder,
Rett syndrome, and pervasive developmental disorder not otherwise specified. Autistic
disorder was characterized by impairments in three domains: social communication,
restricted and repetitive behaviors, and aberrant language development and usage. A
less extensive form of autism spectrum disorder, Asperger’s disorder, did not include
language impairment as a diagnostic criterion. Recent clinical consensus has shifted the
conceptualization of autism spectrum disorder toward a continuum model in which
heterogeneity of symptoms is recognized as inherent in the disorder, and core diagnostic
impairments are collapsed into two domains: deficits in social communication, and
restricted and repetitive behaviors. Aberrant language development and usage is no
longer considered a core feature of autism spectrum disorder. This diagnostic change, is
based, in part, on recent studies in siblings with diagnoses of autistic disorder,
suggesting that symptom domains may be transmitted separately, and that aberrant
language development and usage is not a defining feature, but an associated feature in
some individuals with autism spectrum disorder. Autism spectrum disorder is typically
evident during the second year of life, and in severe cases, a lack of developmentally
appropriate interest in social interactions may be noted even in the first year. Some
studies suggest that a decline in social interaction may ensue between the first and
second years of life. However, in milder cases, core impairments in autism spectrum
disorder may not be identified for several more years. Although language impairment is
not a core diagnostic criterion in autism spectrum disorder, clinicians and parents share
concerns about a child who by 12 to 18 months has not developed any language, and

delayed language accompanied by diminished social behavior are frequently the
heralding symptoms in autism spectrum disorder. In up to 25 percent of cases of autism
spectrum disorder, some language develops and is subsequently lost. Autism spectrum
disorder in children with normal intellectual function and mild impairment in language
function may not be identified until middle childhood when both academic and social
demands are increased. Children with autism spectrum disorder often exhibit
idiosyncratic intense interest in a narrow range of activities, resist change, and
typically, do not respond to their social environment in accordance with their peers.
According to the DSM-5, diagnostic criteria for autism spectrum disorder include
deficits in social communication and restricted interests, which present in the early
developmental period, however, when subtle, may not be identified until several years
later. approximately one third of children meeting the current DSM-5 diagnosis of
autism spectrum disorder, exhibit intellectual disability (ID).
Of interest, is that according to DSM-IV-TR, Rett syndrome or disorder appeared to
occur exclusively in females and is characterized by normal development for at least 6
months, followed by stereotyped hand movements, a loss of purposeful motions,
diminishing social engagement, poor coordination, and decreasing language use. In the
formerly labeled childhood disintegrative disorder, development progresses normally for
approximately 2 years, after which the child shows a loss of previously acquired skills in
two or more of the following areas: language use, social responsiveness, play, motor
skills, and bladder or bowel control. The former Asperger’s disorder is characterized by
impairment in social relatedness and repetitive and stereotyped patterns of behavior
without a delay or marked aberrant in language development and usage. In Asperger’s
disorder, cognitive abilities and major adaptive skills are age appropriate, although
social communication is impaired. A survey of children undertaken with the former
autism spectrum disorders, revealed that the average age of diagnosis was 3.1 years for
children with autistic disorder, 3.9 years for children diagnosed with pervasive
developmental disorder not otherwise specified, and 7.2 years for those youth with
Asperger’s disorder. Children with autism spectrum disorder who exhibited severe
language deficits received an autism spectrum disorder diagnosis, on average, a year
earlier than children without impairment in language. Children with autism spectrum
disorder who exhibited repetitive behaviors such as hand-flapping, toe-walking, and odd
play were also identified with autism spectrum disorder disorders at a younger age than
those who did not exhibit such behaviors. The current DSM-5 autism spectrum disorder
criteria provide specifiers for severity of the main domains of impairment and also
specifiers for the presence or absence of language impairment and intellectual
impairment.
HISTORY OF AUTISTIC DISORDER
“Early infantile autism” was described by Leo Kanner in 1943; however, even as early as 1867, the psychiatrist Henry
Maudsley had observed a group of very young children with severe mental disorders characterized by marked deviation,
delay, and distortion in development. In that era, most serious developmental disturbance in young children was believed

to fall within the category of psychoses. Kanner’s classic paper “Autistic Disturbances of Affective Contact,” coined the
term infantile autism and provided a clear, comprehensive account of the early childhood syndrome. Kanner described
children who exhibited extreme “autistic aloneness”; failure to assume an anticipatory posture; delayed or deviant
language development with echolalia and often with pronominal reversal (using you for I); monotonous repetitions of
noises or verbal utterances; excellent rote memory; limited range of spontaneous activities, stereotypies, and mannerisms;
and anxiously obsessive desire for the maintenance of sameness and dread of change. Socially, Kanner’s sample was
described as having poor eye contact; awkward relationships; and a preference for pictures and inanimate objects. Kanner
suspected that the syndrome was more frequent than it seemed, and suggested that some children with infantile autism
may have been misclassified as “mentally retarded” or schizophrenic. Before 1980, children with symptoms of autism
spectrum disorder were generally diagnosed with childhood schizophrenia. Over time, it became evident that autism
spectrum disorder and schizophrenia were two distinct psychiatric entities. In some cases, however, a child with autism
spectrum disorder may develop comorbid schizophrenic disorder later in childhood.
EPIDEMIOLOGY
Prevalence
Autism spectrum disorders have been increasingly diagnosed over the last two decades,
with the current prevalence estimated at approximately 1 percent in the United States.
Autistic disorder, based on DSM-IV-TR criteria, is believed to occur at a rate of about 8
cases per 10,000 children (0.08 percent). By definition, the onset of autism spectrum
disorder is in the early developmental period; however, some cases are not recognized
until the child is much older. Because of this delay between onset and diagnosis, the
prevalence rates increase with age in young children.
Sex Distribution
Autism spectrum disorder is diagnosed four times more often in boys than in girls. In
clinical samples, girls with autism spectrum disorder more often exhibit intellectual
disability than boys. One potential explanation for this is that girls with autism
spectrum disorder without intellectual disability may be less likely to be identified,
referred clinically, and diagnosed.
ETIOLOGY AND PATHOGENESIS
Genetic Factors
Family and twin studies suggest that autism spectrum disorder has a significant heritable
contribution; however, it does not appear to be fully penetrant. Although up to 15
percent of cases of autism spectrum disorder appear to be associated with a known
genetic mutation, in most cases, its expression is dependent on multiple genes. Family
studies have demonstrated increased rates of autism spectrum disorder in siblings of an
index child, as high as 50 percent in some families with two or more children with
autism spectrum disorder. Siblings of a child with autism spectrum disorder are also at
increased risk for a variety of developmental impairments in communication and social

skills, even when they do not meet criteria for autism spectrum disorder.
The concordance rate of autistic disorder in two large twin studies was 36 percent in
monozygotic pairs versus 0 percent in dizygotic pairs in one study and about 96 percent
in monozygotic pairs versus about 27 percent in dizygotic pairs in the second study.
High rates of cognitive impairments, in the nonautistic twin in monozygotic twins with
perinatal complications, suggest that contributions of perinatal environmental factors
interact with genetic vulnerability differentially in autism spectrum disorder.
The heterogeneity in expression of symptoms in families with autism spectrum
disorder suggests that there are multiple patterns of genetic transmission. Studies
indicate that both an increase and decrease in certain genetic patterns may be risk
factors for autism spectrum disorder. In addition to specific genetic factors, gender plays
a strong role in the expression of autism spectrum disorder. Genetic studies have
identified two biological systems that are influenced in autism spectrum disorder: the
consistent finding of elevated platelet serotonin (5-HT), and the mTOR, that is,
mammalian target of rapamycin–linked synaptic plasticity mechanisms, which appear
to be disrupted in autism spectrum disorder. These will be discussed further in the next
section.
A number of known genetically caused syndromes include autism spectrum disorder as
part of a broader phenotype. The most common of these inherited disorders is fragile X
syndrome, an X-linked recessive disorder that is present in 2 to 3 percent of individuals
with autism spectrum disorder. Fragile X syndrome exhibits a nucleotide repeat in the 5’
untranslated region of the FMNR1 gene, resulting in symptoms of autism spectrum
disorder. Children with fragile X syndrome characteristically exhibit intellectual
disability, gross and fine motor impairments, an unusual facies, macroorchidism, and
significantly diminished expressive language ability. Tuberous sclerosis, another genetic
disorder characterized by multiple benign tumors, inherited by autosomal dominant
transmission, is found with greater frequency among children with autism spectrum
disorder. Up to 2 percent of children with autism spectrum disorder also have tuberous
sclerosis.
Researchers who screened the DNA of more than 150 pairs of siblings with autism
spectrum disorder found evidence of two regions on chromosomes 2 and 7 containing
genes that may contribute to autism spectrum disorder. Additional genes hypothesized to
be involved in autism spectrum disorder were found on chromosomes 16 and 17.
Biomarkers in Autism Spectrum Disorder
Autism spectrum disorder is associated with several biomarkers, potentially resulting
from interactions of genes and environmental factors, which then influence neuronal
function, dendrite development, and contribute to altered neuronal information
processing. Several biomarkers of abnormal signaling in the 5-HT system, the mTORlinked synaptic plasticity mechanisms, and alterations of the γ-aminobutyric acid
(GABA) inhibitory system.
The first biomarker identified in autism spectrum disorder was elevated serotonin in

whole blood, almost exclusively in the platelets. Platelets acquire 5-HT through the
process of SERT (serotonin transporter), known to be hereditary, as they pass through
the intestinal circulation. The genes that mediate SERT (SLC64A), and the 5-HT receptor
5-HT 2A gene (HTR2A) are known to be more heritable than autism spectrum disorder,
and encode the same protein in the platelets and in the brain. Because 5-HT is known to
be involved in brain development, it is possible that the changes in 5-HT regulation may
lead to alterations in neuronal migration and growth in the brain.
Both structural and functional neuroimaging studies have suggested specific
biomarkers associated with autism spectrum disorder. Several studies found increased
total brain volume in children younger than 4 years of age with autism spectrum
disorder, whose neonatal head circumferences were within normal limits or slightly
below. By about age 5 years, however, 15 to 20 percent of children with autism
spectrum disorder developed macrocephaly. Additional studies found confirmatory data
in samples of infants who were later diagnosed with autism spectrum disorder, who
exhibited normal head circumferences at birth; by 4 years, 90 percent had larger brain
volumes than controls, with 37 percent of the autism spectrum disorder group meeting
criteria for macrocephaly. In contrast, structural magnetic resonance imaging (sMRI)
studies of children with autism spectrum disorder ranging from 5 to 16 years did not
find mean values of total brain volume increased. One study followed the size of the
amygdala in youth with autism spectrum disorder in the first few years of life, and
similarly, found an increased size in the first few years of life, followed by a decrease in
size over time. The size of the striatum has also been found in several studies to be
enlarged in young children with autism spectrum disorder, with a positive correlation of
striatal size with frequency of repetitive behaviors. The dynamic process of the atypical
and changing total brain volume observed in children with autism spectrum disorder
lends support for the overarching hypothesis that there are sensitive periods or “critical
periods” within the brain’s plasticity that may be disrupted in ways that may contribute
to the emergence of autism spectrum disorder.
Functional MRI (fMRI) studies have focused on identifying biomarkers, that is, the
functional brain correlates of various observed core symptoms in autism spectrum
disorder. fMRI studies of children, adolescents, and adults with autism spectrum disorder
have employed tasks including face perception, neutral face tasks, “theory of mind”
deficits, language and communication impairments, working memory and repetitive
behaviors. fMRI studies have provided evidence that individuals with autism spectrum
disorder have a tendency to scan faces differently than controls, in that they focus more
on the mouth region of the face rather than on the eye region and rather than scan the
entire face multiple times, individuals with autism spectrum disorder focus more on
individual features of the face. In response to socially relevant stimuli, researchers have
come to the conclusion that individuals with autism spectrum disorder have greater
amygdala hyperarousal. In terms of “theory of mind,” that is, the ability to attribute
emotional states to others, and to oneself, fMRI studies find differences in activation in
brain regions such as the right temporal lobe and other areas of the brain known to
become activated in controls during tasks involving theory of mind. This difference has

been hypothesized by some researchers to represent dysfunction of the mirror neuron
system (MNS). Atypical patterns of frontal lobe activation have been found in multiple
studies of autism spectrum disorder during face processing tasks, suggesting that this
area of the brain may be critical in social perception and emotional reasoning.
Decreased activation in individuals with autism spectrum disorder in the left frontal
regions of the brain during memory and language-based tasks led researchers to
hypothesize that individuals with autism spectrum disorder utilized more visual
strategies during language processing than controls did.
Both sMRI and fMRI research has contributed to demonstrating brain correlates of
core impairments observed in individuals with autism spectrum disorder.
Immunological Factors
Several reports have suggested that immunological incompatibility (i.e., maternal
antibodies directed at the fetus) may contribute to autistic disorder. The lymphocytes of
some autistic children react with maternal antibodies, which raises the possibility that
embryonic neural tissues may be damaged during gestation. These reports usually reflect
single cases rather than controlled studies, and this hypothesis is still under
investigation.
Prenatal and Perinatal Factors
A higher-than-expected incidence of prenatal and perinatal complications seems to occur
in infants who are later diagnosed with autism spectrum disorder. The most significant
prenatal factors associated with autism spectrum disorder in the offspring are advanced
maternal and paternal age at birth, maternal gestational bleeding, gestational diabetes,
and first-born baby. Perinatal risk factors for autism spectrum disorder include umbilical
cord complications, birth trauma, fetal distress, small for gestational age, low birth
weight, low 5-minute Apgar score, congenital malformation, ABO blood group system or
Rh factor incompatibility and hyperbilirubinemia. Many of the obstetrical complications
that are associated with risk for autism spectrum disorder are also risk factors for
hypoxia, which may be an underlying risk factor itself. There is not sufficient evidence
to implicate any one single perinatal or prenatal factor in autism spectrum disorder
etiology, and a genetic predisposition to autism spectrum disorder may be interacting
with perinatal factors.
Comorbid Neurological Disorders
Electroencephalography (EEG) abnormalities and seizure disorders occur with greater
than expected frequency in individuals with autism spectrum disorder. Four percent to
32 percent of individuals with autism spectrum disorder have grand mal seizures at
some time, and about 20 to 25 percent show ventricular enlargement on computed
tomography (CT) scans. Various EEG abnormalities are found in 10 to 83 percent of
children with the previously defined autistic disorder, and although no EEG finding is

specific to autistic disorder, there is some indication of failed cerebral lateralization. The
current consensus is that autism spectrum disorder is a set of behavioral syndromes
caused by a multitude of factors acting on the central nervous system.
Psychosocial Theories
Studies comparing parents of children with autism spectrum disorder with parents of
normal children have shown no significant differences in child-rearing skills. Kanner’s
early speculations that parental emotional factors might be implicated as contributing
to the development of autism spectrum disorder have been clearly refuted.
DIAGNOSIS AND CLINICAL FEATURES
The DSM-5 diagnostic criteria for autism spectrum disorder are shown in Table 31.5-1.
Table 31.5-1
DSM-5 Diagnostic Criteria for Autism Spectrum Disorder

Core Symptoms of Autism Spectrum Disorder
Persistent Deficits In Social Communication and Interaction.
 Children
with autism spectrum disorder characteristically do not conform to the expected level of
reciprocal social skills and spontaneous nonverbal social interactions. Infants with
autism spectrum disorder may not develop a social smile, and as older babies may lack
the anticipatory posture for being picked up by a caretaker. Less frequent and poor eye
contact is common during childhood and adolescence compared to other children. The
social development of children with autism spectrum disorder is characterized by
atypical, but not absent, attachment behavior. Children with autism spectrum disorder
may not explicitly acknowledge or differentiate the most important persons in their
lives—parents, siblings, and teachers—and on the other hand, may not react as strongly

to being left with a stranger compared to others their age. Children with autism
spectrum disorder often feel and display extreme anxiety when their usual routine is
disrupted. By the time children with autism spectrum disorder reach school age, their
social skills may have increased, and social withdrawal may be less obvious, particularly
in higher-functioning children. An observable deficit, however, often remains in
spontaneous play with peers and in subtle social abilities that promote developing
friendships. The social behavior of children with autism spectrum disorder is often
awkward and may be inappropriate. In older school-aged children, social impairments
may be manifested in a lack of conventional back and forth conversation, fewer shared
interests, and fewer body and facial gestures during conversations. Cognitively, children
with autism spectrum disorder are frequently more skilled in visual-spatial tasks than in
tasks requiring skill in verbal reasoning.
One observation of the cognitive style of children with autism spectrum disorder is an
impaired ability to infer the feelings or emotional state of others around them. That is,
individuals with autism spectrum disorder have difficulty with making attributions about
the motivation or intentions of others (also termed “theory of mind”) and thus have
difficulty developing empathy. The lack of a “theory of mind” produces difficulties
interpreting the social behavior of others and leads to a lack of social reciprocation.
Individuals with autism spectrum disorder generally desire friendships, and higher
functioning children may be aware that their lack of spontaneity and poor skills in
responding to the emotions and feelings of their peers are major obstacles in developing
friendships. Children with autism spectrum disorder are often avoided or shunned by
peers who expect them to conform to their mainstream activities, and experience their
behavior as awkward and alienating. Adolescents and adults with autism spectrum
disorder often desire romantic relationships, and for some, their increase in social
competence and skills over time enables them to develop long-term relationships.
Restricted, Repetitive Patterns of Behavior, Interests, and Activities.
From the first years of life, in a child with autism spectrum disorder, developmentally
expected exploratory play is restricted and muted. Toys and objects may not be used
typically, instead, are often manipulated in a ritualistic manner, with fewer symbolic
features. Children with autism spectrum disorder generally do not show the level of
imitative play or abstract pantomime that other children of their age exhibit
spontaneously. The activities and play of children with autism spectrum disorder may
appear more rigid, repetitive, and monotonous than their peers. Ritualistic and
compulsive behaviors are common in early and middle childhood. Children with autism
spectrum disorder often seem to enjoy spinning, banging, and watching water flowing.
Frank compulsive behaviors are not uncommon among children with autism spectrum
disorder, such as lining up objects, and not infrequently a child with autism spectrum
disorder may exhibit a strong attachment to a particular inanimate object. Children with
autism spectrum disorder who are severely intellectually disabled have increased rates
of self-stimulatory and self-injurious behaviors. Stereotypies, mannerisms, and
grimacing emerge most frequently when a child with autism spectrum disorder is a less-

structured situation. Children with autism spectrum disorder often find transitions and
changes intimidating. Moving to a new house, rearranging furniture in a room, or even
a change such as eating a meal before a bath when the reverse was the routine, may
evoke panic, fear, or temper tantrums in a child with autism spectrum disorder.
Associated Physical Characteristics.
 At first glance, children with autism
spectrum disorder do not show any physical signs indicating the disorder. Children with
autism spectrum disorder, overall, do exhibit higher rates of minor physical anomalies,
such as ear malformations, and others that may reflect abnormalities in fetal
development of those organs along with parts of the brain.
A greater than expected number of children with autism spectrum disorder do not
show early handedness and lateralization, and remain ambidextrous at an age when
cerebral dominance is established in most children. Children with autism spectrum
disorder have been observed to have a higher incidence of abnormal dermatoglyphics
(e.g., fingerprints) than those in the general population. This finding may suggest a
disturbance in neuroectodermal development.
Associated Behavioral Symptoms that May Occur in Autism Spectrum
Disorder
Disturbances In Language Development and Usage.
 Deficits in language
development and difficulty using language to communicate ideas are not among the
core criteria for diagnosing autism spectrum disorder; however, they occur in a subset of
those individuals with autism spectrum disorder. Some children with autism spectrum
disorder are not simply reluctant to speak, and their speech abnormalities do not result
from lack of motivation. Language deviance, as much as language delay, is
characteristic of more severe subtypes of autism spectrum disorder. Children with severe
autism spectrum disorder have significant difficulty putting meaningful sentences
together, even when they have large vocabularies. When children with autism spectrum
disorder whose language was delayed do learn to converse fluently, their conversations
may impart information without typical prosody or inflection.
In the first year of life, a typical pattern of babbling may be minimal or absent. Some
children with autism spectrum disorder vocalize noises—clicks, screeches, or nonsense
syllables—in a stereotyped fashion, without a seeming intent of communication. Unlike
most young children who generally have better receptive language skills than expressive
ones, children with autism spectrum disorder may express more than they understand.
Words and even entire sentences may drop in and out of a child’s vocabulary. It is not
atypical for a child with autism spectrum disorder to use a word once and then not use it
again for a week, a month, or years. Children with autism spectrum disorder may
exhibit speech that contains echolalia, both immediate and delayed, or stereotyped
phrases that seem out of context. These language patterns are frequently associated with
pronoun reversals. A child with autistic disorder might say, “You want the toy” when she
means that she wants it. Difficulties in articulation are also common. Many children

with autistic disorder use peculiar voice quality and rhythm. About 50 percent of autistic
children never develop useful speech. Some of the brightest children show a particular
fascination with letters and numbers. Children with autism spectrum disorder sometimes
excel in certain tasks or have special abilities; for example, a child may learn to read
fluently at preschool age (hyperlexia), often astonishingly well. Very young children
with autism spectrum disorder who can read many words, however, have little
comprehension of the words read.
Intellectual Disability.
 About 30 percent of children with autism spectrum
disorder function in the intellectually disabled range of intellectual function. Of those,
about 30 percent of children function in the mild to moderate range, and about 45 to 50
percent are severely to profoundly intellectually disabled. The intelligent quotient (IQ)
scores of autism spectrum disorder children with intellectual impairments tend to reflect
most severe problems with verbal sequencing and abstraction skills, with relative
strengths in visuospatial or rote memory skills. This finding suggests the importance of
defects in language-related functions.
Irritability.
 Broadly defined, irritability includes aggression, self-injurious
behaviors, and severe temper tantrums. These phenomena are commonly encountered
in children and adolescents with autism spectrum disorder. Severe temper tantrums may
be difficult to subdue, and self-injurious behaviors are often problematic to control.
These symptoms are often produced by everyday situations in which these youth are
expected to transition from one activity to another, sit in a classroom setting, or remain
still when they desire to run around. In children with autism spectrum disorder who are
lower functioning and have intellectual deficits, aggression may emerge unexpectedly
without an obvious trigger or purpose, and self-injurious behaviors such as head
banging, skin picking, and biting oneself may also be noted.
Instability of Mood and Affect.
 Some children with autism spectrum disorder
exhibit sudden mood changes, with bursts of laughing or crying without an obvious
reason. It is difficult to learn more about these episodes if the child cannot express the
thoughts related to the affect.
Response to Sensory Stimuli.
 Children with autism spectrum disorder have been
observed to overrespond to some stimuli and underrespond to other sensory stimuli
(e.g., to sound and pain). It is not uncommon for a child with autism spectrum disorder
to appear deaf, at times showing little response to a normal speaking voice; on the
other hand, the same child may show intent interest in the sound of a wristwatch. Some
children have a heightened pain threshold or an altered response to pain. Indeed, some
children with autism spectrum disorder do not respond to an injury by crying or seeking
comfort. Some youth with autism spectrum disorder perseverate on a sensory
experience; for example, they frequently hum a tune or sing a song or commercial jingle
before saying words or using speech. Some particularly enjoy vestibular stimulation—

spinning, swinging, and up-and-down movements.
Hyperactivity and Inattention.
 Hyperactivity and inattention are both common
behaviors in young children with autism spectrum disorder. Lower than average activity
level is less frequent; when present, it often alternates with hyperactivity. Short
attention span, poor ability to focus on a task, may also interfere with daily functioning
Precocious Skills.
 Some individuals with autism spectrum disorder have precocious
or splinter skills of great proficiency, such as prodigious rote memories or calculating
abilities, usually beyond the capabilities of their normal peers. Other potential
precocious abilities in some children with autism spectrum disorder include hyperlexia,
an early ability to read well (even though they cannot understand what they read),
memorizing and reciting, and musical abilities (singing or playing tunes or recognizing
musical pieces).
Insomnia.
 Insomnia is a frequent sleep problem among children and adolescents
with autism spectrum disorder, estimated to occur in 44 to 83 percent of school-aged
children. Both behavioral and pharmacologic interventions have been applied as
interventions. Behavioral interventions include modification of parental behavior before
and at bedtime, and providing routines that remove reinforcers for remaining awake.
Medication interventions have included melatonin, which appears to be a promising
agent in doses ranging from 1 mg fast-release to 4 mg controlled-release in the few
controlled studies for insomnia in youth with autism spectrum disorder.
Minor Infections and Gastrointestinal Symptoms.
 Young children with
autism spectrum disorder have been reported to have a higher-than-expected incidence
of upper respiratory infections and other minor infections. Gastrointestinal symptoms
commonly found among children with autism spectrum disorder include excessive
burping, constipation, and loose bowel movements. Also seen is an increased incidence
of febrile seizures in children with autism spectrum disorder. Some children do not show
temperature elevations with minor infectious illnesses and may not show the typical
malaise of ill children. In other children, behavior problems and relatedness seem to
improve noticeably during a minor illness, and in some, such changes are a clue to
physical illness.
Assessment Tools
A standardized instrument that can be very helpful in eliciting comprehensive
information regarding autism spectrum disorder is the Autism Diagnostic Observation
Schedule-Generic (ADOS-G).
Brett was the first of two children born to middle-class parents both in their early
40s after difficult pregnancy, with an induced labor at 36 weeks due to fetal distress.

As an infant, Brett was undemanding and relatively placid; he did not have colic, and
motor development proceeded appropriately, but language development was delayed.
Brett’s parents first became concerned about his development when he was 18 months
of age and still not speaking; however, upon questioning, they noted that, in
comparison to other toddlers in his play group, Brett had seemed less uninterested in
social interaction and the social games with toddlers and adults. Stranger anxiety
became marked at 18 months, much later compared to the other toddlers in his day
care program. Brett would become extremely upset if his usual day care worker was
not present and would tantrum until his mother took him home. Brett’s pediatrician
initially reassured his parents that he was a “late talker”; however, when Brett was 24
months old he was referred for developmental evaluation. At 24 months, motor skills
were age appropriate. His language and social development, however, was severely
delayed, and he was noted to be resistant to changes in routine and unusually
sensitive to aspects of the inanimate environment. Brett’s play skills were quite
limited, and he played with toys in repetitive and idiosyncratic ways. His younger
sister, now 12 months, was beginning to say a few words, and the family history was
negative for language and developmental disorders. A comprehensive medical
evaluation revealed a normal EEG and CT scan; genetic screening and chromosome
analysis were normal as well.
Brett was diagnosed with autism spectrum disorder, and he was enrolled in a
special education program in which he gradually began to speak. His speech was
extremely literal and characterized by a monotonic voice quality and an occasional
pronoun reversal. Brett often spoke and was able to make his needs known; however,
his language was odd and the other toddlers did not play with him. Brett pursued
mainly solo activities and remained quite isolated. By age 5 years, Brett was quite
attached to his mother and often became separation anxious and upset when she went
out, exhibiting severe tantrums. Brett also had developed a number of self-stimulatory
behaviors in which he engaged, such as waving his fingers in front of his eyes. His
extreme sensitivity to change continued over the next few years. Intelligence testing
revealed a full-scale IQ in the average range with relative weakness in the verbal
subtests compared to the performance subtests. In the 4th grade, Brett began to have
serious behavioral problems at school and at home. Brett was unable to complete his
class work, would wander around the classroom, and would begin to tantrum when
the teacher insisted that he sit in his seat. He would sometimes begin screaming so
loudly that he had to be asked to leave the classroom. He would then become upset
and throw all of his books off his desk in a rage, sometimes inadvertently hitting other
students. It took him up to 2 hours to calm down. At home, Brett would fly into a
tantrum if anyone touched his things, and he would become stubborn and belligerent
when asked to do anything that he was not expecting. Brett’s tantrum behavior
continued into middle school, and by the 8th grade, when he was 13 years old, these
behaviors became so severe that the school warned his parents that he was becoming
unmanageable. Brett was evaluated by a child and adolescent psychiatrist who

recommended a social skills group for him and prescribed risperidone, starting with
0.5 mg p.o. b.i.d. and titrating up to 1.5 mg p.o. bid. At that dose, Brett’s tantrums
were less frequent and less severe. Brett seemed calmer in general, and did not
become physically out of control during tantrums. Brett continued in middle school in
a combination of special education classes and regular classes. Brett’s social skills
group was helpful in terms of teaching him how to approach peers in ways that would
lead to less rejection. Brett had made some acquaintances, and by the time he started
high school, he had acquired two friends who would come to his home and play video
games with him. Brett knew that he was different than the other students, but he had
trouble articulating what was different about him. Brett continued in high school with
a combination of special and regular education and had plans to attend a community
college and live at home for the first year.
(Adapted from a case by Fred Volkmar, M.D.)
DIFFERENTIAL DIAGNOSIS
Disorders to consider in the differential diagnosis of autism spectrum disorder include
social (pragmatic) communication disorder, the newly described DSM-5 communication
disorder; schizophrenia with childhood onset; congenital deafness or severe hearing
disorder; and psychosocial deprivation. It is also difficult to make the diagnosis of
autism spectrum disorder because of its potentially overlapping symptoms with
childhood schizophrenia, intellectual disability syndromes with behavioral symptoms,
and language disorders. In view of the many concurrent problems often encountered in
autism spectrum disorder, Michael Rutter and Lionel Hersov suggested a stepwise
approach to the differential diagnosis.
Social (Pragmatic) communication disorder
This disorder is characterized by difficulty in conforming to typical storytelling,
understanding the rules of social communication through language, exemplified by a
lack of conventional greeting others, taking turns in a conversation, and responding to
verbal and nonverbal cues of a listener. Other forms of language impairment may
accompany social communication disorder such as delay in learning language or
expressive and receptive difficulties. Social communication disorder is found with
greater frequency in relatives of individuals with autism spectrum disorder, which
increases the difficulty in discriminating this disorder from autism spectrum disorder.
Although relationships may be negatively affected by social communication disorder,
this disorder does not include restricted or repetitive behaviors and interests, as autism
spectrum disorder does.
Childhood Onset Schizophrenia
Schizophrenia is rare in children younger than 12 years and almost nonexistent before

the age of 5 years. Characterized by hallucinations or delusions, childhood onset
schizophrenia has a lower incidence of seizures and intellectual disability and poor
social skills. Table 31.5-2 compares autism spectrum disorder and schizophrenia with
childhood onset.
Table 31.5-2
Autism Spectrum Disorder versus Childhood Onset Schizophrenia
Intellectual Disability with Behavioral Symptoms
Children with intellectual disability may exhibit behavioral symptoms that overlap with
some autism spectrum disorder features. The main differentiating features between
autism spectrum disorder and intellectual disability are that children with intellectual
disability syndromes generally display global impairments in both verbal and nonverbal
areas, whereas children with autism spectrum disorder are relatively weak in social
interactions compared to other areas of performance. Children with intellectual
disability generally relate verbally and socially to adults and peers in accordance with
their mental age, and they exhibit a relatively even profile of limitations.
Language Disorder
Some children with language disorders also have autism spectrum disorder features,
which may present a diagnostic challenge. Table 31.5-3 summarizes the major
differences between autism spectrum disorder and language disorders.
Table 31.5-3
Autism Spectrum Disorder versus Language Disorder

Congenital Deafness or Hearing Impairment
Because children with autism spectrum disorder may appear mute or lack language
development, congenital deafness and hearing impairment must be considered and
ruled out. Differentiating factors include the following: infants with autism spectrum
disorder may babble only infrequently, whereas deaf infants often have a history of
relatively normal babbling that then gradually tapers off and may stop at 6 months to 1
year of age. Deaf children generally respond only to loud sounds, whereas children with
autism spectrum disorder may ignore loud or normal sounds and respond to soft or low
sounds. Most importantly, audiogram or auditory-evoked potentials indicate significant
hearing loss in deaf children. Deaf children usually seek out nonverbal social
communication with regularity and seek social interactions with peers and family
members more consistently than children with autism spectrum disorder.
Psychosocial Deprivation
Severe neglect, maltreatment, and lack of parental care can lead children to appear
apathetic, withdrawn, and alienated. Language and motor skills may be delayed.
Children with these signs generally improve when placed in a favorable and enriched
psychosocial environment, but such improvement is not the case with children with
autism spectrum disorder.
COURSE AND PROGNOSIS
Autism spectrum disorder is typically a lifelong, albeit heterogeneous, disorder with a
highly variable severity and prognosis. Children with autism spectrum disorder and IQs
above 70 with average adaptive skills, who develop communicative language by ages 5
to 7 years, have the best prognoses. A longitudinal study comparing symptoms in
children with high-IQ autism spectrum disorder at the age of 5 years, with their
symptoms at age 13 through young adulthood, found that a small proportion no longer
met criteria for autism spectrum disorder. Most of these youth demonstrated positive

changes in communication and social domains over time. Early intensive behavioral
interventions have been found to provide a profound positive impact on many children
with autism spectrum disorder, and in some cases lead to recovery and function in the
average range.
The autism spectrum disorder symptom areas that do not seem to improve
substantively over time with early behavioral interventions are related to ritualistic and
repetitive behaviors. However, currently, evidence-based behavioral interventions
specifically targeting repetitive behaviors may ameliorate them. The prognosis of a
given child with autism spectrum disorder is generally improved if the home
environment is supportive.

TREATMENT
The goals of treatment for children with autism spectrum disorder are to target core
behaviors to improve social interactions, communication, broaden strategies to integrate
into schools, develop meaningful peer relationships, and increase long-term skills in
independent living. Psychosocial treatment interventions aim to help children with
autism spectrum disorder to develop skills in social conventions, increase socially
acceptable and prosocial behavior with peers, and to decrease odd behavioral
symptoms. In many cases, language and academic remediation are also required. In
addition, treatment goals generally include reduction of irritable and disruptive
behaviors that may emerge in school and at home and may exacerbate during
transitions. Children with intellectual disability require developmentally appropriate
behavioral interventions to reinforce socially acceptable behaviors and encourage selfcare skills. In addition, parents of children with autism spectrum disorder often benefit
from psychoeducation, support, and counseling in order to optimize their relationships
and effectiveness with their children. Comprehensive treatment for autism spectrum
disorder including intensive behavioral programs, parent training and participation,
and academic/educational interventions have provided the most promising results.
Components of these comprehensive treatments include expanding social skills,
communication, and language, often through practicing imitation, joint attention, social
reciprocity, and play in a directed but child-centered manner. Five randomized
controlled trials (RCTs) of early intensive comprehensive behavioral interventions
targeting core features of autism spectrum disorder in children ranging in age from 2
years to 5 years of age have shown increases in language acquisition, social
interactions, and educational achievement at the end of the study period compared to
control groups. The study periods ranged from 12 weeks to several years, and the
settings were at home, in clinic, or at school. The comprehensive treatment models or
adapted versions of them were used either alone or in combinations in these RCTs as
described below.
Psychosocial Interventions
Early Intensive Behavioral and Developmental Interventions
1. UCLA/Lovaas-based Model. This intensive and manualized intervention primarily
utilizes techniques derived from applied behavior analysis, which is administered on a
one-to-one basis for many hours per week. A therapist and a child will work on
practicing specific social skills, language usage, and other target play skills, with
reinforcement and rewards provided for accomplishments and mastery of skills.
2. Early Start Denver Model (ESDM) Interventions are administered in naturalistic
settings such as in day care, at home, and during play with other children. Parents are
typically taught to be co-therapists and provide the training at home while
educational settings also provide the interventions. The focus of the interventions is

on developing basic play skills and relationship skills, and applied behavior analysis
techniques are integrated into the interventions. This approach is focused on training
for very young children and is applied within the context of the child’s daily routine.
3. Parent Training Approaches This includes Pivotal Response Training, in which
parents are taught to facilitate social and communication development within the
home and during activities by targeting gateway or pivotal social behaviors for
mastery by the child with the expectation that once these central social skills were
mastered, a natural generalizing of social behaviors would follow. Extensive parent
and family components are integrated into this type of intervention. Other parent
training approaches focus on language acquisition, and for parents, may be
administered at a lower intensity such as weekly; however, once parents are trained,
the interventions occur throughout the day with the child. Another example of a
parent training approach is the Hanen More Than Words Program.
Social Skills Approaches
1. Social Skills Training. Typically provided by therapeutic leaders to children of
various ages in a group setting with peers; children are given guided practice in
initiating social conversation, greetings, initiating games, and joint attention.
Emotion identification and regulation are often included in practice with recognizing
and learning how to label emotions in given social situations, learning to attribute
appropriate emotional reactions in others, and social problem-solving techniques. The
goals are that with practice in the group setting, the child will be able to use the
techniques in less-structured settings and internalize strategies to interact positively
with peers.
Behavioral Interventions (BIs) and Cognitive-Behavioral Therapy (CBT)
for Repetitive Behaviors and Associated Symptoms
1. Behavioral Therapy. Applied behavioral analysis has been found to be somewhat
effective in reducing some repetitive behaviors in children and adolescents with
autism spectrum disorder. Early intervention is recommended for repetitive behaviors
that are self-injurious; behavioral interventions may need to be combined with
pharmacologic treatments to adequately manage the symptoms.
2. Cognitive-Behavioral Therapy. There is a significant evidence base from RCTs for
the efficacy of CBT for symptoms of anxiety, depression, and obsessive-compulsive
disorders in children. There are fewer controlled trials of this treatment in children
with autism spectrum disorder, although there are at least two published studies in
which CBT was used to treat repetitive behavior in individuals with autism spectrum
disorder.
Interventions for comorbid symptoms in autism spectrum disorder
1. Neurofeedback. This modality has been administered in an attempt to influence

symptoms of attention-deficit/hyperactivity disorder (ADHD), anxiety, and increased
social interaction by providing computer games or other games in which the desired
behavior is reinforced, while the child wears electrodes that monitor electrical activity
in the brain. The aim is to influence brainwave activity to prolong or produce
electrical activity present during the desired behaviors. This modality is still under
investigation in the treatment of symptoms in autism spectrum disorder.
2. Management of insomnia in autism spectrum disorder. Insomnia is a prevalent
concern among children and adolescents with autism spectrum disorder, and both
behavioral and pharmacologic interventions may be administered to improve this
condition. The most common behavioral intervention for insomnia in autism spectrum
disorder is based on changing the parents behavior first toward the child at bedtime
and throughout the night, such that there is a removal of reinforcement and attention
for being awake, leading to a gradual extinction of the “staying awake” behavior.
Several studies using massage therapy before bedtime in children with autism
spectrum disorder between the ages of 2 years and 13 years provided an improvement
in falling asleep and a sense of relaxation.
Educational interventions for children with autism spectrum disorder
1. Treatment and Education of Autistic and Communication-related Handicapped
children (TEACCH). Originally developed at the University of North Carolina at
Chapel Hill in the 1970s, TEACCH involves structured teaching based on the notion
that children with autism spectrum disorder have difficulty with perception, and so
this teaching method incorporates many visual supports and a picture schedule to aid
in teaching academic subjects as well as socially appropriate responses. The physical
environment is arranged to support visual learning, and the day is structured to
promote autonomy and social relatedness.
2. Broad-based approaches. These educational plans include a blend of teaching
strategies that use behavioral analysis and also focus on language remediation.
Behavioral reinforcement is provided for socially acceptable behaviors while academic
subjects are being taught. TEACCH may also be incorporated into a broader special
educational program for autism spectrum disorder.
3. Computer-based approaches and virtual reality. Computer-based approaches and
virtual reality teaching are centered on using computer-based programs, games, and
interactive programs to teach language acquisition and reading skills. This provides
the child with a sense of mastery and delivers a behaviorally based instruction in a
modality that is appealing for the child. The Let’s Face It! program is a computerized
game that helps to teach children with autism spectrum disorder to recognize faces. It
consists of seven interactive computer games that target changes in facial expression,
attention to the eye region of the face, holistic face recognition, and identifying
emotional expression. A randomized controlled trial of use of this program with
children with autism spectrum disorder provided evidence that after 20 hours of face
training with Let’s Face It!, compared to the control group, the trained children

demonstrated improvement in their ability to focus on the eye region of a face and
improved their analytic and holistic face-processing skills. Several studies using virtual
reality environments to teach children with autism spectrum disorder social skills and
interaction have provided evidence of their value. In one study, a virtual café for
children with autism spectrum disorder allowed the children to practice ordering and
paying for drinks and food by navigation with the use of a computer mouse.
Psychopharmacological Interventions
Psychopharmacological interventions in autism spectrum disorder are mainly directed at
ameliorating impairing associated behavioral symptoms rather than core features of
autism spectrum disorder. Target symptoms include irritability, broadly including
aggression, temper tantrums and self-injurious behaviors, hyperactivity, impulsivity,
and inattention.
Irritability.
 Two second-generation antipsychotics, risperidone and aripiprazole,
have been approved by the Food and Drug Administration (FDA) in the United States for
treatment of irritability in individuals with autism spectrum disorder. Risperidone, a
high-potency antipsychotic with combined dopamine (D2) and serotonin (5-HT2)
receptor antagonist properties, has been shown to subdue aggressive or self-injurious
behaviors in children with and without autism spectrum disorder. Starting with the
National Institutes of Health supported Research Units on Pediatric
Psychopharmacology randomized controlled trial of risperidone for treating irritability
in autism spectrum disorder in 2002, there have been seven randomized controlled
trials, three reanalysis studies, and two add-on studies, which have converged to confirm
risperidone as an efficacious pharmacological treatment for irritability in children and
adolescents with autism spectrum disorder in doses ranging from 0.5 mg to 1.5 mg.
Some of the preschoolers in this study were also receiving intensive behavioral
treatments. Risperidone is considered the first-line of medication treatment for children
and adolescents with autism spectrum disorder who exhibit severe irritability. Despite its
efficacy, risperidone’s main side effects of weight gain and increased appetite; metabolic
side effects such as hyperglycemia, prolactin elevation, and dyslipidemia; along with
other common adverse effects such as fatigue, drowsiness, dizziness, and drooling have
limited its use in some individuals. Risperidone should be used with caution in
individuals with underlying cardiac abnormalities or hypotension, since risperidone may
contribute to orthostatic hypotension. In further continuation studies of risperidone in
the treatment of irritability in autism spectrum disorder, persistent efficacy and
tolerability were found over a 6-month period, with a rapid return of symptoms in good
responders when the risperidone was discontinued. Other drugs studied in the treatment
of irritability in autism spectrum disorder include aripiprazole and olanzapine.
Two large studies utilizing aripiprazole in the treatment of tantrums, aggression, and
self-injury in children and adolescents with autism spectrum disorder found that
aripiprazole was both efficacious and safe. Doses ranged from 5 mg to 15 mg per day.

Main side effects included sedation, dizziness, insomnia, akathisia, nausea, and
vomiting. Although weight gain was not as pronounced as with risperidone, it was still
considered a moderate adverse event, with approximately 1.3 to 1.5 kg gained during
an 8-week study period. The weight gain was similar at the lower and higher doses.
Olanzapine, which specifically blocks 5-HT2A and D2 receptors and also blocks
muscarinic receptors, has been studied in children and adolescents with autism spectrum
disorder for the treatment of irritability with a trend toward a positive response;
however, significant weight gain of approximately 3.5 kg occurred. The main side effect
was sedation.
Hyperactivity, Impulsivity, and Inattention.
 Several randomized placebocontrolled trials of methylphenidate have been conducted for the treatment of
hyperactivity, impulsivity, and inattention in children and adolescents with autism
spectrum disorder. The Research Units of Pediatric Psychopharmacology found
methylphenidate to be at least moderately efficacious at doses of 0.25 to 0.5 mg/kg for
youth with autism spectrum disorder and ADHD symptoms. Efficacy of methylphenidate
in this population was less effective than in children with ADHD without autism
spectrum disorder, and children with autism spectrum disorder developed more frequent
side effects, including increased irritability, compared to ADHD children. A study of
methylphenidate in the treatment of hyperactivity and inattention in preschoolers with
autism spectrum disorder found the stimulant safe and relatively efficacious; half of the
preschoolers developed side effects including increased stereotypies, gastrointestinal
upset, sleep problems, and emotional lability. Among nonstimulants, one double-blind
placebo-controlled study of hyperactivity, impulsivity, and inattention using
atomoxetine in children with autism spectrum disorder found that it was significantly
more effective than placebo. Side effects included sedation, irritability, constipation,
and nausea. Clonidine, an α-agonist has also been studied in children with autism
spectrum disorder for the treatment of hyperactivity with mixed results. Guanfacine was
also found to be of use in some cases.
Repetitive and Stereotypic Behavior.
 These core symptoms of autism spectrum
disorder have been studied using selective serotonin reuptake inhibitor (SSRI)
antidepressants, second-generation antipsychotics (SGAs), and mood-stabilizing agents
such as valproate. One study with fluoxetine found the medication group only slightly
better and not significantly better than the placebo group regarding the target
symptoms, and another trial with escitalopram found no difference between groups.
Risperidone, however, was found to be effective in targeting irritability, and restrictive
and repetitive behaviors were improved. One recent study using valproate in a 12-week
trial with 55 children with a mean age of 9½ years with autism spectrum disorder,
found that those who were considered responders with respect to irritability were also
found to be spending less time engaging in repetitive behaviors.

Agents Administered For Behavioral Impairment In Autism Spectrum
Disorder Based On Open Trials.
 Quetiapine is an antipsychotic with more
potent 5-H2 than D2 receptor blocking properties. Although only open-label trials have
been done with this agent, it is sometimes tried when risperidone and olanzapine are
not efficacious or well tolerated. It has been used in clinical practice at doses ranging
from 50 to 200 mg per day. Adverse effects include drowsiness, tachycardia, agitation,
and weight gain.
Clozapine has a heterocyclic chemical structure that is related to certain conventional
antipsychotics, such as loxapine (Loxitane), although clozapine carries a lower risk of
extrapyramidal symptoms. It is not generally used in the treatment of aggression and
self-injurious behavior unless those behaviors coexist with psychotic symptoms. The most
serious adverse effect is agranulocytosis, which necessitates monitoring white blood cell
count weekly during clozapine use. Its use is generally limited to treatment-resistant
psychotic patients.
Ziprasidone has receptor-blocking properties at the 5-HT2A and D2 receptor sites and
carries little risk of extrapyramidal and antihistaminic effects. No guidelines exist for its
use in autistic children with aggressive and self-injurious behaviors, but it has been used
clinically to treat the latter behaviors in children who are treatment resistant. In studies
of its use in adults with schizophrenia, dose ranges of 40 to 160 mg were found to be
effective. Adverse effects include sedation, dizziness, and lightheadedness. An
electrocardiography (ECG) recording is generally obtained before use of this medication.
Lithium (Eskalith) has been shown to be efficacious in children with aggression
without autism spectrum disorder, and it is used clinically in the treatment of aggressive
or self-injurious behaviors when antipsychotic medications are not effective.
Agents Used For Behavioral Impairment In Autism Spectrum Disorder
Without Evidence Of Efficacy.
 A double-blind study investigated the efficacy of
amantadine (Symmetrel), which blocks N-methyl-d-aspartate (NMDA) receptors, in the
treatment of behavioral disturbance, such as irritability, aggression, and hyperactivity,
in children with autism. Some researchers have suggested that abnormalities of the
glutamatergic system may contribute to the emergence of autism spectrum disorders.
High glutamate levels have been found in children with the formerly labeled Rett
syndrome. In the amantadine study, 47 percent of children on amantadine were rated
“improved” by their parents, and 37 percent of children on placebo were rated
“improved” by parents in irritability and hyperactivity, although this difference was not
statistically significant. Investigators rated the children on amantadine “significantly
improved” with respect to hyperactivity. A double-blind, placebo-controlled study of the
efficacy of the anticonvulsant lamotrigine (Lamictal) on hyperactivity in children with
autism showed high rates of placebo improvement in ratings of hyperactivity, which
were similar to response on the medication.
Clomipramine (Anafranil) has been used in autism spectrum disorder, without RCTs to
provide evidence of positive results. Fenfluramine (Pondimin), which reduces blood

serotonin levels, has also been used unsuccessfully in the treatment of autism.
Improvement does not seem to be associated with a reduction in blood serotonin level.
Naltrexone (ReVia), an opioid receptor antagonist, has been investigated without much
success, based on the notion that blocking endogenous opioids would reduce autistic
symptoms.
Tetrahydrobiopterin, a coenzyme that enhances the action of enzymes was used in a
double-blind placebo-controlled crossover study of 12 children with autistic disorder and
low concentrations of spinal tetrahydrobiopterin. The children received a daily dose of 3
mg tetrahydrobiopterin per kilogram during a 6-month period alternating with placebo.
Results indicated small, nonsignificant changes in the total scores on the Childhood
Autism Rating Scale after 3- and 6-month treatment. Post hoc analysis of the three core
symptoms of autism—social interaction, communication, and stereotyped behaviors—
revealed a significant improvement in social interaction score after 6 months of active
treatment. A positive correlation was noted between social response and IQ. These
results suggest that there is a possible effect of tetrahydrobiopterin on the social
functioning of children with autism.
A recent case report suggested that low-dose venlafaxine (Effexor) was efficacious in
three adolescents and young adults with autistic disorder with self-injurious behavior
and hyperactivity. Dose of venlafaxine used was 18.75 mg per day, and efficacy was
reported to be sustained over a 6-month period.
Complementary and Alternative Medicine (CAM) Approaches to Autism
Spectrum Disorder
Complementary and alternative medicine (CAM) is a group of nontraditional treatments
that are generally used in conjunction with conventional treatments. Safe interventions
that have been applied to target both core and associated behavioral features of autism
spectrum disorder with unknown efficacy include the following: music therapy, to
promote communication and expression; and yoga, to promote attention and decrease
activity level. A biologically based practice that is deemed safe and shown to be
efficacious is melatonin, which is effective in reducing sleep-onset latency in children.
Other biological practices that are recognized as safe but with unknown efficacy include
vitamin C, multivitamins, essential fatty acids, and the amino acids carnosine and
carnitine. Secretin has been shown to be ineffective in RCTs in the treatment of autism
spectrum disorder.
DISORDERS INCLUDED IN AUTISTIC SPECTRUM DISORDER
The autistic spectrum covers a range of behaviors which, prior to the change in the DSM5 were listed separately, and which are now no longer diagnosed as separate entities in
the diagnostic manual. Nevertheless, the descriptive value of these entities remains
important, and it may be some time before the disorders described herein disappear
from the psychiatric lexicon. In addition, they remain in use in Europe and around the

world as useful diagnostic entities and are still coded as separate disorders in ICD-10 as
discussed.
International Classification of Diseases, Tenth Edition (ICD-10)
The classification system used in International Classification of Diseases, Tenth Revision
(ICD-10) is not congruent with the revisions made in DSM-5 about autistic disorders.
ICD-10 still includes separate designations for Rett syndrome, Childhood Disintegrative
Disorder, Asperger’s Disorder, and Pervasive Development Disorder Not Otherwise
Specified (Table 31.5-4). The authors of Synopsis believe these subtypes to be clinically
useful, and each is described below. The reader should be aware, however, that
according to DSM-5, each is subsumed under the rubric of Autism Spectrum Disorder and
should so be diagnosed.
Table 31.5-4
ICD-10 Diagnostic Criteria for Pervasive Developmental Disorders

Rett Syndrome
In 1965, Andreas Rett, an Australian physician, identified a syndrome in 22 girls who

appeared to have developed normally for at least 6 months followed by devastating
developmental deterioration. Rett syndrome is a progressive condition that has its onset
after some months of what appears to be normal development. Head circumference is
normal at birth and developmental milestones are unremarkable in early life. Between 5
and 48 months of age, generally between 6 months and 1 year, head growth begins to
decelerate.
Available data indicate a prevalence of 6 to 7 cases of Rett syndrome per 100,000
girls. Originally, it was believed that Rett syndrome occurred only in females, but males
with the disorder or syndromes that are very close to this disorder have now been
described. Rett syndrome is not fully included within autism spectrum disorder, and if
present along with autism spectrum disorder it should be diagnosed as an associated
disorder.
Etiology.
 The cause of Rett syndrome is unknown, although the progressive
deteriorating course after an initial normal period is compatible with a metabolic
disorder. In some patients with Rett syndrome, the presence of hyperammonemia has
led to postulation that an enzyme metabolizing ammonia is deficient, but
hyperammonemia has not been found in most patients with Rett syndrome. It is likely
that Rett syndrome has a genetic basis. It has been seen primarily in girls, and case
reports so far indicate complete concordance in monozygotic twins.
Diagnosis and Clinical Features.
 During the first 5 months after birth, infants
have age-appropriate motor skills, normal head circumference, and normal growth.
Social interactions show the expected reciprocal quality. At 6 months to 2 years of age,
however, these children develop progressive encephalopathy with a number of
characteristic features. The signs often include the loss of purposeful hand movements,
which are replaced by stereotypic motions, such as hand-wringing; the loss of previously
acquired speech; psychomotor retardation; and ataxia. Other stereotypical hand
movements may occur, such as licking or biting the fingers and tapping or slapping. The
head circumference growth decelerates and produces microcephaly. All language skills
are lost, and both receptive and expressive communicative and social skills seem to
plateau at developmental levels between 6 months and 1 year. Poor muscle
coordination and an apraxic gait with an unsteady and stiff quality develop.
Associated features include seizures in up to 75 percent of affected children and
disorganized EEG findings with some epileptiform discharges in almost all young
children with Rett syndrome, even in the absence of clinical seizures. An additional
associated feature is irregular respiration, with episodes of hyperventilation, apnea, and
breath holding. The disorganized breathing occurs in most patients while they are
awake; during sleep, the breathing usually normalizes. Many patients with Rett
syndrome also have scoliosis. As the disorder progresses, muscle tone seems to change
from an initial hypotonic condition to spasticity to rigidity.
Although children with Rett syndrome may live for well over a decade after the onset
of the disorder, after 10 years, many patients are wheelchair-bound, with muscle

wasting, rigidity, and virtually no language ability. Long-term receptive and expressive
communication and socialization abilities remain at a developmental level of less than 1
year.
Dana was born as a full-term and healthy baby term after an uncomplicated
pregnancy. An amniocentesis had been obtained because of advanced maternal age of
40 years, and findings were normal. At birth, Dana received good Apgar scores and
her weight, height, and head circumference were all near the 50th percentile. Her
development during the first months of life was unremarkable. At approximately 8
months of age, her development seemed to wane, and her interest in the
environment, including the social environment, declined. Dana’s developmental
milestones failed to progress, and she became markedly delayed; she was just starting
to walk at her second birthday and had no spoken language. Evaluation at that time
revealed that head growth had decelerated. Self-stimulatory behaviors emerged, and
in addition, marked cognitive and communicative delays were noted on formal
testing. Dana began to lose purposeful hand movements and developed unusual
stereotypical hand-washing behaviors. By age 6, her EEG was abnormal and abnormal
hand movements were prominent. Subsequently, Dana developed truncal ataxia and
breath-holding spells, and motor skills further deteriorated. (Adapted from Fred
Volkmar, M.D.)
Differential Diagnosis.
 Rett syndrome shares some features with autism spectrum
disorder; however, the two disorders have some predictable differences. In Rett
syndrome, there is deterioration of developmental milestones, head circumference, and
overall growth, whereas in autism spectrum disorder, aberrant development is usually
present from early on. In Rett syndrome, specific and characteristic hand motor
movements are always present; in autism spectrum disorder hand mannerisms may or
may not appear. Poor coordination, ataxia, and apraxia are predictably part of Rett
syndrome; however, individuals with autism spectrum disorder may have unremarkable
gross motor function. In Rett syndrome, verbal abilities are usually lost completely,
whereas in autism spectrum disorder language is widely variable from markedly
aberrant to relatively mildly impaired. Respiratory irregularity is characteristic of Rett
syndrome, and seizures often appear early. In autistic disorder, no respiratory
disorganization is seen, and seizures do not develop in most patients; when seizures do
develop, they are more likely in adolescence than in childhood. For autism spectrum
disorder that is associated with another neurodevelopmental disorder such as Rett
syndrome, the latter disorder is diagnosed in association with autism spectrum disorder.
Course and Prognosis.
 Rett syndrome is progressive, and those individuals who
live into adolescence and adulthood function at a cognitive and social level equivalent
to that in the first year of life.

Treatment.
 Treatment is symptomatic. Physiotherapy has been beneficial for the
muscular dysfunction, and anticonvulsant treatment is usually necessary to control the
seizures. Behavior therapy, along with medication, may help control self-injurious
behaviors, as it does in the treatment of autistic disorder, and it may help regulate the
breathing disorganization.
Childhood Disintegrative Disorder
The previous diagnosis of childhood disintegrative disorder, now included in autism
spectrum disorder, is characterized by marked regression in several areas of functioning
after at least 2 years of apparently normal development. Childhood disintegrative
disorder, also called Heller’s syndrome and disintegrative psychosis, was described in 1908
as a deterioration over several months of intellectual, social, and language function
occurring in 3- and 4-year-olds with previously normal function. After the deterioration,
the children closely resembled children with autistic disorder.
Epidemiology.
 Epidemiological data have been complicated by the variable
diagnostic criteria used, but childhood disintegrative disorder is estimated to be much
less common than the formerly diagnosed autistic disorder. The prevalence has been
estimated to occur in about 1 in 100,000 boys. The ratio of boys to girls is estimated to
be between 4 and 8 boys to 1 girl.
Etiology.
 The cause of childhood disintegrative disorder is unknown, but it has been
associated with other neurological conditions, including seizure disorders, tuberous
sclerosis, and various metabolic disorders.
Diagnosis and Clinical Features.
 The diagnosis is made based on features that
fit a characteristic age of onset, clinical picture, and course. Cases reported have ranged
in onset from ages 1 to 9 years, but in most, the onset is between 3 and 4 years.
Whereas previously diagnosed as a separate entity, DSM-5 conceives of childhood
disintegrative disorder as a subset of autism spectrum disorder. The onset may be
insidious over several months or relatively abrupt, with abilities diminishing in days or
weeks. In some cases, a child displays restlessness, increased activity level, and anxiety
before the loss of function. The core features of the disorder include loss of
communication skills, marked regression of reciprocal interactions, and the onset of
stereotyped movements and compulsive behavior. Affective symptoms are common,
particularly anxiety, as is the regression of self-help skills, such as bowel and bladder
control.
To receive the diagnosis, a child must exhibit loss of skills in two of the following
areas: language, social or adaptive behavior; bowel or bladder control; play; and motor
skills. Abnormalities must be present in both of the following categories: reciprocal
social communication skills, and restricted and repetitive behavior. The main
neurological associated feature is seizure disorder.

Ron’s early history was within normal limits. By age 2, he was speaking in
sentences, and his development appeared to be proceeding appropriately. At 3½
years of age, he abruptly exhibited a period of marked behavioral regression shortly
after the birth of a sibling. Ron lost previously acquired skills in communication and
was no longer toilet trained. Ron became more withdrawn and less interested in
social 
interaction, 
exhibiting 
various 
self-stimulatory 
behaviors 
repeatedly.
Comprehensive medical examination failed to reveal any conditions that might
account for this developmental regression. Behaviorally, Ron exhibited features of
autism spectrum disorder. At follow-up at age 12, he spoke only an occasional single
word and had severe mental retardation. (Adapted from Fred Volkmar, M.D.)
Differential Diagnosis.
 The differential diagnosis of the formerly diagnosed
childhood disintegrative disorder includes receptive and expressive language disorder,
mental retardation with behavioral problems, and Rett syndrome. Childhood
disintegrative disorder is characterized by the loss of previously acquired development.
Before the onset of childhood disintegrative disorder (occurring at 2 years or older),
language has usually progressed to sentence formation. This skill is strikingly different
from the premorbid history of even high-functioning patients with autistic disorder, in
whom language generally does not exceed single words or phrases before diagnosis of
the disorder. Once the disorder occurs, however, those with childhood disintegrative
disorder are more likely to have no language abilities than are high-functioning patients
with autistic disorder. In Rett syndrome, the deterioration occurs much earlier than in
childhood disintegrative disorder, and the characteristic hand stereotypies of Rett
syndrome do not occur in childhood disintegrative disorder.
Course and Prognosis.
 The course of childhood disintegrative disorder is variable,
with a plateau reached in most cases, a progressive deteriorating course in rare cases,
and some improvement in occasional cases to the point of regaining the ability to speak
in sentences. Most patients are left with at least moderate mental retardation.
Treatment.
 Treatment of childhood disintegrative disorder includes the same
components available in the treatment of autistic disorder.
Asperger’s Disorder
The former diagnosis of Asperger’s disorder is characterized by impairment and oddity
of social interaction and restricted interest and behavior. Unlike the former autistic
disorder, in Asperger’s disorder there are no significant delays in language or cognitive
development. In 1944, Hans Asperger, an Austrian physician, described a syndrome that
he named “autistic psychopathy.” His original description of the syndrome described
individuals with normal intelligence who exhibit a qualitative impairment in reciprocal
social interaction and behavioral oddities without delays in language development.

Asperger’s disorder occurs in a wide variety of severities, including cases in which very
subtle social cues are missed, but overall social interactions are mastered.
Etiology.
 Asperger’s disorder, a version of autism spectrum disorder, has a complex
etiology including genetic contribution and potentially environmental and perinatal
contributing factors.
Diagnosis and Clinical Features.
 The clinical features include at least two of
the following indications of qualitative social impairment: Markedly abnormal
nonverbal communicative gestures, the failure to develop peer relationships at the
expected level. Restricted interests and patterns of behavior are present, but when they
are subtle, they may not be immediately identified or singled out as different from those
of other children. According to DSM-IV-TR, individuals with Asperger’s disorder exhibit
no language delay, clinically significant cognitive delay, or adaptive impairment.
Currently, the clinical phenotype of Asperger’s disorder is subsumed within the DSM-5
diagnosis of autism spectrum disorder.
Jared was an only child. Birth, medical, and family histories were unremarkable.
His motor development was slightly delayed, but language milestones were within
normal limits. His parents became concerned about him at age 4 when he was
enrolled in a nursery school and was noted to have difficulties in peer interaction,
joining activities, and following the rules that were so pronounced that he could not
continue in the program. In grade school, he was enrolled in regular education classes
and was noted to have difficulties making friends and playing sports with the other
students, and he often played alone and spent time alone at lunch and recess. His
greatest difficulties arose in peer interactions—he was viewed as eccentric and did not
seem to understand how to interact with peers. At home, he seemed captivated by
watching the weather channel on television, which he insisted on watching and
pursued with great interest and intensity. On examination at age 13, Jared had
markedly restricted and intense interests and exhibited pedantic and odd patterns of
communication with a monotonic voice quality. Psychological testing revealed an IQ
within the normal range. Formal communication examination revealed ageappropriate skills in receptive and expressive language but marked impairment in
pragmatic language skills. (Adapted from Fred Volkmar, M.D.)
Differential Diagnosis.
 The differential diagnosis includes social anxiety disorder,
obsessive-compulsive disorder, and schizoid personality disorder. According to the
previous DSM-IV-TR, the most obvious characteristics of Asperger’s disorder compared to
autistic disorder are the absence of language delay and dysfunction. The lack of
language delay and impaired use of language were previous requirements for Asperger’s
disorder; however, social and communication deficits are present. Studies comparing

children with Asperger’s disorder and autistic disorder found that children with
Asperger’s disorder were more likely to seek social interaction, and due to their
awareness of their impairment sought more vigorously to make friends. Although in this
subgroup within autism spectrum disorder significant delay in language is not a feature,
some delay in the acquisition of language, and some impairment in verbal
communication has been noted in more than one third of clinical samples.
Course and Prognosis.
 The factors associated with a good prognosis in this
subgroup within autism spectrum disorder are a normal IQ and more competencies in
social skills. Reports of some adults diagnosed with Asperger’s disorder indicate that
their social and communication deficits remain and they continue to relate in an
awkward way and appear socially uncomfortable.
Treatment.
 Treatment of individuals who meet the criteria for the previous
Asperger’s disorder diagnosis aims to promote social communication and peer
relationships. Interventions are initiated with the goal of shaping interactions so that
they better match those of peers. Very often children with Asperger’s disorder are highly
verbal and have excellent academic achievement. The tendency of children and
adolescents with Asperger’s disorder to rely on rigid rules and routines can become a
source of difficulty for them and be an area that requires therapeutic intervention. A
comfort with routines, however, can be utilized to foster positive habits that may
enhance the social life of a child with Asperger’s disorder. Self-sufficiency and problemsolving techniques are often helpful for these individuals in social situations and work
settings. Some of the same techniques used for autistic disorder are likely to benefit
patients with Asperger’s disorder with severe social impairment.
Pervasive Developmental Disorder Not Otherwise Specified
Whereas the DSM-IV-TR defines pervasive disorder not otherwise specified as a
condition with severe, pervasive impairment in communication skills or the presence of
restricted and repetitive activities and associated impairment in social interactions,
DSM-5 conceives of this as encompassed within a diagnosis of autism spectrum disorder.
Anna was the older of two children. She had been a difficult baby who was not easy
to console but her motor and communicative development seemed appropriate. She
was socially related and sometimes enjoyed interaction, but she was easily
overstimulated. She exhibited some hand flapping behavior, especially when she was
excited. Anna’s parents sought evaluation when she was 4 years of age because of
problems with getting along with other children. At evaluation Anna was found to
have language and cognitive function within the normal range. Anna had difficulty
relating to her parents as sources of support and comfort. She displayed behavioral
rigidity and a tendency to impose routines on social skills. Anna was placed in a
special education kindergarten and did well academically, although problems in peer

interactions and unusual affective responses persisted. As an adolescent, Anna
describes herself as a “loner,” who often retreats from others and avoids social
interaction and tends to be comfortable with solitary activities. (Adapted from Fred
Volkmar, M.D.)
Treatment.
 The treatment approach is identical to that of other autism spectrum
disorder. Mainstreaming in school may be possible. Compared with previously
diagnosed autistic children, those with the former pervasive developmental disorder not
otherwise specified generally have less impairment in language skills and more selfawareness.
REFERENCES
Akins RS, Angkustiri K, Hansen RL. Complementary and alternative medicine in autism: An evidence-based approach to
negotiating safe and efficacious interventions with families. Neurotherapeutics. 2010;7:307–319.
Aman MG, Arnold MKLE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ,
Chuang S, Martin A, Shah B, Gonzalez HM, Swiezy NB, Ritz L, Koenig K, McGough J, Ghuman JK, Lindsay RL. Acute
and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol.
2005;15:869.
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; Centers for
Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders—Autism and Developmental
Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009,58:1–20.
Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: Implications for explaining autism. Science.
2005;310:819.
Bishop DV, Mayberry M, Wong D, Maley A, Hallmayer J. Characteristics of the broader phenotype in autism: A study of
siblings using the children’s communication checklist-2. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:117–122.
Boyd BA, McDonough SG, Bodfish JW. Evidence-based behavioral interventions for repetitive behaviors in autism. J
Autism Dev Disord. 2011;1284–1294.
Canitano R, Scandurra V. Psychopharmacology in autism: An update. Prog Neuropsychopharmacol Biol Psychiatry.
2011;35:18–28.
Carminati GG, Deriaz N, Bertschy G. Low-dose venlafaxine in three adolescents and young adults with autistic disorder
improves self-injurious behavior and attention deficit/hyperactivity disorder (ADHD)-like symptoms. Prog
Neuropsychopharmacol Biol Psychiatry. 2006;30:312.
Constantino JN, Lajonchere C, Lutz M, Gray T, Abbacchi A, McKenna K, Singh D, Todd RD. Autistic social impairment in
the siblings of children with pervasive developmental disorders. Am J Psychiatry. 2006;163:294–296.
Danfors T, von Knorring AL, Hartvig P, Langstrom B, Moulder R, Stromberg B, Tortenson R, Wester U, Watanabe Y, EegOlofsson O. Tetrahydrobiopterin in the treatment of children with autistic disorder: A double-blind placebo-controlled
crossover study. J Clin Psychopharmacol. 2005;25:485.
Gadow KD, DeVincent CJ, Pomeroy J. ADHD symptom subtypes in children with pervasive developmental disorder. J
Autism Dev Disord. 2006;36(2): 271–223.
Gardener H, Spiegelman D, Buka SL. Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis.
Pediatrics. 2011;128:344–355.
Hazlett HC, Poe, M, Gerig C, Smith RG, Provenzale J, Ross A, Gilmore J, Piven J. Magnetic resonance imaging and head

circumference study of brain size in autism: Birth through age 2 years. Arch Gen Psychiatry. 2005;62:1366.
Huffman LC, Sutcliffe TL, Tanner ISD, Feldman HM. Management of symptoms in children with autism spectrum
disorders: A comprehensive review of pharmacologic and complementary-alternative medicine treatments. J Dev Behav
Pediatr. 2011;32:56–68.
Kasari C, Lawton K. New directions in behavioral treatment of autism spectrum disorders. Curr Opin Neurol. 2010;23:137–
143.
Ke JY, Chen CL, Chen YJ, Chen CH, Lee LF, Chiang TM. Features of developmental functions and autistic profiles in
children with fragile X syndrome. Chang Gung Med J. 2005;28:551.
Koyama T, Tachimori H, Osada H, Kurita H. Cognitive and symptom profiles in high-functioning pervasive developmental
disorder not otherwise specified and attention-deficit/hyperactivity disorder. J Autism Dev Disord. 2006;36(3): 373–380.
Lehmkuhl, HD, Storch E, Bodfish JW, Geffken GR. Brief Report: Exposure and response prevention for obsessive
compulsive disorder in a 12-year-old with autism. J Autism Dev Disord. 2008;38:977–981.
Mandell DS, Novak MM, Zubritsky CD. Factors associated with age of diagnosis among children with autism spectrum
disorders. Pediatrics. 2005;116:1480.
Miano S, Ferri Raffaele. Epidemiology and management of insomnia in children with autistic spectrum disorder. Pediatr
Drugs. 2010;12:75–84.
Nazeer A. Psychopharmacology of autistic spectrum disorders in children and adolescents. Pediatr Clin N Am. 2011;58:85–
97.
Owley T, Walton L, Salt J, Guter SJ, Winnega M, Leventhal BL, Cook EH. An open–label trial of escitalopram in pervasive
developmental disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:343.
Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled crossover trial of
methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266.
Robinson EB, Koenen KC, McCormick MC, Munir K, Hallet V, Happe F, Plomin R, Ronald A. Evidence that autistic traits
show the same etiology in the general population an at the quantitative extremes (5 percent, 2.5 percent, and 1 percent).
Arch Gen Psychiatry. 2011;68:1113–1121.
Rogers SJ, Vismara LA. Evidence-based comprehensive treatments for early autism. J Clin Child Adolesc Psychol.
2008;37:8–38.
Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: A decade of new twin studies. Am J Med Genet Part
B. 2011;156:255–274.
Research Units on Pediatric Psychopharmacology Autism Network (RUPPAN). Risperidone treatment of autistic disorder:
Longer-term benefits and blinded discontinuation after 6 months. Am J Psychiatry. 2005;162:1361–1369.
Stigler KA, McDonald BC, Anand A, Saykin AJ, McDougle CJ. Structural and functional magnetic resonance imaging of
autism spectrum disorders. Brain Res. 2011;1380:146–161.
Sugie Y, Sugie H, Fukuda T, Ito M. Neonatal factors in infants with autistic disorder and typically developing infants.
Autism. 2005;5:487–494.
Tanaka JW, Wolf JM, Klaiman C, Koenig K, Cockburn J, Herlihy L, Brown C, Stahl S, Kaiser MD, Schultz RT. Using
computerized games to teach face recognition skills to children with autism spectrum disorder: the Let’s Face it!
Program. J Child Psychol Psychiatry. 2010;51:944–952.
Vanderbuilt Evidence-based Practice Center, Nashville TN. Therapies for children with autism spectrum disorders.
Comparative Effectiveness Review 2011; 26;1–13.
Veenstra-VanderWeele J, Blakely RD. Networking in Autism: Leveraging genetic, biomarker and model system findings in
the search for new treatments. Neuropsychopharmacology. 2012;37:196–212.
Volkmar FR, Klin A, Schultz RT, State M. Pervasive developmental disorders. In: Sadock BJ, Sadock VA, Ruiz P. eds.